Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

88 results about "Design synthesis" patented technology

In-vitro screening method for antineoplastic activity of artemisinin and derivatives of artemisinin

InactiveCN104897887ARapid and effective judgment of anti-tumor activityLow costColor/spectral properties measurementsBiological testingFluorescence spectraScreening method
The invention discloses an in-vitro screening method for antineoplastic activity of artemisinin and derivatives of the artemisinin. The method comprises the following steps: analyzing the interaction between the artemisinin or the derivatives of the artemisinin and transferrin by adopting ultraviolet-visible absorption spectra or fluorescence spectra; calculating the combining factor Kb of the artemisinin or the derivatives of the artemisinin and the transferring; comparing the combining factor Kb of the artemisinin or the derivatives of the artemisinin and the transferring, or sequencing according to the combining factor Kb, and inferring the strength sequence of the antineoplastic activity of the artemisinin or the derivatives of the artemisinin; and verifying screening results by adopting antineoplastic activity tests. According to the method, a spectroscopic method is used for detecting the combining factor Kb of the artemisinin or the derivatives of the artemisinin and the transferring, and the in-vitro screening is carried out on the antineoplastic activity of the artemisinin and the derivatives of the artemisinin according to the sequence of the combining factor Kb. By using the method, the antineoplastic activity of the derivatives of the artemisinin can be fast and effectively judged, the method can be used for providing the base for designed synthesis of artemisinin-based drugs and clinical application of the artemisinin-based drugs, and promoting the application of the artemisinin-based drugs in the antineoplastic field.
Owner:NANJING NORMAL UNIVERSITY

Inverse linear quadratic control method of hot continuous rolling thickness-loop synthetic system

The invention relates to an inverse linear quadratic control method of a hot continuous rolling thickness-loop synthetic system. According to dynamic models of a loop control system and a automatic gauge control system, a continuous state space model of the hot continuous rolling thickness-loop synthetic system is established by using a state space analysis method; based on the established continuous state space model, proper sampling periods are selected, a zero-order holder method is adopted, the obtained continuous model is subjected to discretization, and a discrete state space model of the hot continuous rolling thickness-loop synthetic system is obtained; and on this basis, the inverse linear quadratic controller (ILQ) of the synthetic system is designed. According to the inverse linear quadratic control method of the hot continuous rolling thickness-loop synthetic system, in an existing hot continuous rolling control system, the automatic gauge control (AGC) system and the loopcontrol system are regarded as two independent control systems, and the problem of multivariable coupling between systems cannot be processed is solved; and according to the technical scheme providedby the embodiment of the inverse linear quadratic control method of the hot continuous rolling thickness-loop synthetic system, the coordinated optimization control of the thickness, tension and anglein the hot continuous rolling control system can be realized.
Owner:HUAQIAO UNIVERSITY

Symmetrical binuclear ruthenium complex and preparation method utilizing microwave

The invention relates to a symmetrical binuclear ruthenium complex and a preparation method utilizing microwave, belonging to the technical field of synthetic chemistry. The preparation method comprises the following steps: firstly reacting 2-acetylpyridine with 4-bromobenzaldehye as a starting raw material, wherein traditional NaOH and CH3OH are respectively replaced with KOH and EtOH to further shorten reaction time; performing cross-coupling reaction to the obtained terpyridyl compound and diethyl phosphite, wherein the P-H bond in diethyl phosphite is cut off by taking triethylamine as a salt base; then synthesizing an intermediate complex together with ruthenium trichloride hydrate RuCl3.3H2O, and then synthesizing a target product under microwave conditions. The complex molecules can be adsorbed onto a conductive substrate such as an ITO and the like by taking phosphoryl groups at two ends of the complex molecules as fixed ligands and layer-by-layer self assembling can be realized, and the symmetrical binuclear ruthenium complex is an excellent photosensitive dye. The symmetrical binuclear ruthenium complex is simple in design synthesis process and low in cost, and the microwave-assisted synthesis technology is fast and efficient.
Owner:KUNMING UNIV OF SCI & TECH

Human interleukin29 mature peptide mutant (hIL-29Z) with arginine and lysine produced respectively by site-directed mutagenesis of 33th lysine and 35th arginine and preparation method thereof

The invention provides a human interleukin29 mature peptide mutant (hIL-29Z) with arginine and lysine produced respectively by site-directed mutagenesis of 33th lysine and 35th arginine and a preparation method thereof. The preparation method comprises the following steps of 1, carrying out artificial design synthesis of a site-directed mutagenesis primer, 2, carrying out site-directed mutagenesis of 98th and 104th basic groups of a hIL-29 mature peptide encoding gene by the site-directed mutagenesis primer, 3, constructing a recombinant eukaryotic expression vector containing a hIL-29 mutant encoding gene, and carrying out pichia pastoris transformation to obtain recombinant engineered yeast, 4, carrying out culture of the recombinant engineered yeast, and adding 1.5% (v/v) of methanol into the culture solution so that hIL-29 mutant expression is induced, and 5, through SP-Sepharose Fast Flow cation-exchange chromatography, carrying out purification of the hIL-29 mutant in the supernatant of the culture solution. The engineered yeast obtained by the invention can be subjected to high-density culture, can secrete and express the hIL-29Z with arginine and lysine produced respectively by site-directed mutagenesis of 33th lysine and 35th arginine, and is suitable for industrial preparation of hIL-29 mature peptide mutants.
Owner:JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products